local_hospital

Azienda Sanitaria Locale di Potenza

Address
Via Torraca, 2, 85100 Potenza, Italy

Azienda Sanitaria Locale di Potenza - Pain Management Research Center

The Azienda Sanitaria Locale di Potenza is a healthcare institution actively engaged in clinical research focused on musculoskeletal disorders and pain management. The center specializes in evaluating innovative therapeutic approaches for acute and chronic pain conditions that affect a significant portion of the adult population.

  • Acute and chronic low back pain treatment strategies
  • Comparative efficacy studies of analgesic and anti-inflammatory medications
  • Fixed-dose combination therapies for musculoskeletal pain relief

The research program emphasizes evidence-based approaches to managing acute moderate-severe low back pain, a condition affecting approximately 80% of adults at least once during their lifetime. Through controlled clinical trials, the center investigates mechanisms underlying disk-, muscle-, and posterior articulation-related pain, with the goal of achieving early maximum pain relief while improving patient mobility and physical function. Their research methodology employs validated assessment tools including Visual Analogic Scale (VAS) measurements to objectively evaluate treatment efficacy and optimize therapeutic outcomes for patients with disabling musculoskeletal conditions.

Site Overview

assignment
1
connected trial
corporate_fare
1
sponsor
science
4
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
1
Total trials linked
Low Activity
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
1
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 566 other sites in Italy

description
Trial volume
1
Outperforms 1% of sites
public
Therapeutic diversity
1areas
Outperforms 1% of sites
groups
Sponsor diversity
1sponsors
Outperforms 1% of sites

Therapeutic Area Benchmark — Italy

Select a therapeutic area to compare against other sites in Italy.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Italy

Market Share

Country: Italy

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Azienda Sanitaria Locale di Potenza

Trial Sponsor Phase Status Start Date End Date
Evaluation of the Efficacy of Diclofenac Sodium and Thiocolchicoside Combination Versus Diclofenac Sodium and Placebo in Acute Moderate-Severe Low Back PainEpifarma S.r.l.Phase IIINot RecruitingMar 2023Jun 2025

IMP list

lock Showing 1 of 4 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Diclofenac1Unknown2023-03-302023-03-30

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.